Drug or treatment
Inetetamab clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Inetetamab that are recruiting, in China. By phase: Phase 4 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SKB264 with inetetamab for HER2-positive advanced breast cancer after progression on T-DXd | Phase 2 | Shanghai | Recruiting | Sep 19, 2025 |
| Evaluating Inetetamab combinations for treating HER2 positive metastatic breast cancer | Phase 4 | Shanwei, Guangdong | Recruiting | Oct 15, 2024 |
| Treatment for locally advanced HER2-positive breast cancer using a combination of drugs | — | Wenzhou, Zhejiang | Recruiting | Jan 31, 2024 |
| Combining inetetamab, pyrotinib, and vinorelbine for treating advanced HER2-positive breast cancer | — | Hangzhou, Zhejiang | Recruiting | May 12, 2023 |
All recruiting trials (4)
-
SKB264 with inetetamab for HER2-positive advanced breast cancer after progression on T-DXd
This trial will see if combining SKB264 and inetetamab helps adults with HER2-positive unresectable or metastatic breast cancer whose disease progressed after trastuzumab deruxtecan (T-DXd).
-
Evaluating Inetetamab combinations for treating HER2 positive metastatic breast cancer
This study is testing if a new drug called Inetetamab, used with either Pertuzumab or Pyrotinib, can improve treatment for people with HER2 positive metastatic breast cancer.
-
Treatment for locally advanced HER2-positive breast cancer using a combination of drugs
This study is testing a new combination of drugs to see if it can help women with locally advanced HER2-positive breast cancer get better before surgery.
-
Combining inetetamab, pyrotinib, and vinorelbine for treating advanced HER2-positive breast cancer
This study is testing a new combination of three drugs to see if they can help people with advanced HER2-positive breast cancer feel better and live longer.
Quick answers
How many clinical trials of Inetetamab are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.